Piper Sandler Companies, a leading investment bank, is pleased to announce the addition of Patrick McCormack, M.D. as a managing director in the healthcare investment banking group. McCormack will be based in San Francisco and focused on advising biopharma companies on mergers and acquisitions and capital-raising transactions.
Read More on Fintech : Global Fintech Interview with Baran Ozkan, co-founder & CEO of Flagright
“We are excited to welcome Patrick to the healthcare investment banking team. His deep expertise advising biopharma companies across the full spectrum of equity and M&A transactions, combined with his rare scientific and clinical perspective, makes him an exceptional addition to our group. Patrick’s extensive relationships with management teams, boards of directors and investors across the sector will further strengthen our ability to deliver outstanding outcomes for our clients,” said Peter Day, global group head of healthcare investment banking at Piper Sandler.
“Piper Sandler has built one of the most respected healthcare investment banking franchises in the industry, and I am excited to join such a talented and driven team. I look forward to leveraging my experience advising biopharma companies to help clients navigate complex transactions and create long-term value,” said McCormack.
Prior to joining Piper Sandler, McCormack worked at Wells Fargo Securities, where he served as an executive director in biopharma investment banking. Before Wells Fargo, he held senior roles at Goldman Sachs & Co., SVB Leerink and SunTrust Robinson Humphrey. McCormack also brings a distinguished scientific and clinical background, having earned his doctor of medicine degree from the University of Louisville School of Medicine and completed a residency in internal medicine and anesthesiology. He holds a Master of Business Administration degree from Vanderbilt University and a bachelor’s degree in microbiology and cell sciences from the University of Florida.
Catch more Fintech Insights : Real-Time Payments and the Redefinition Of Global Liquidity
[To share your insights with us, please write to psen@itechseries.com ]
